glp-1 biotech Boston secures Series A funding to move its once-weekly obesity patch into first-in-human clinical trials. ㅤ Link in bio. ㅤ #longevity #obesity #glp1 #clinicaltrials #biotech The next phase of the

J Clin Med (2018) 7(12):549

doi: 10.1210/jc.2006-1926 59 CountsDRGwirtsmanHCarlssonLMLesemMCutlerGBJr.The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins

GSH is a crucial intracellular small-molecule reducing agent that effectively removes ROS and plays a vital role in the redox homeostasis of tumor cells (43)

This metabolic vulnerability, however, also presents a prime therapeutic target for metabolic modulators such as GLP-1RAs

Tirzepatide imitates a human hormone produced naturally by the gut, pancreas, and nervous system (GLP-1)